Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 75 (1) , 67-72
- https://doi.org/10.1016/0021-9150(89)90208-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjectsAtherosclerosis, 1988
- Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- CS-514 Suppresses Plasma Triglyceride in Hypertriglyceridemic Subjects Without Modifying a Lipoprotein Structural ModelHormone and Metabolic Research, 1987
- Effects of CS-514, a New Inhibitor of HMG CoA Reductase, on Plasma Lipids, Lipoproteins and Apoproteins in Patients with Primary HypercholesterolemiaHormone and Metabolic Research, 1986
- The Effect of CS-514, an Inhibitor of HMG-CoA Reductase, on Serum Lipids in Healthy VolunteersAtherosclerosis, 1986
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1983
- Hyperglycemia and Plasma Lipid LevelsNew England Journal of Medicine, 1980
- Lipoproteins and plasma cholesterol esterification in normal and diabetic subjectsAtherosclerosis, 1979
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965